• Company
• New CKD drug Kerendia is expected to receive reimb soon
• by Eo, Yun-Ho Jan 4, 2024 05:33am

• Company
• Only 1 of 10 CEOs ‘positive’ about drug regulations in KOR
• by Chon, Seung-Hyun Jan 3, 2024 07:28pm

• Product
• KPDS demands gov. action to end chemotherapy drug shortages
• by Kang, Hye-Kyung Jan 3, 2024 05:40am

• Policy
• Comprehensive Health Insurance Plan to be released soon
• by Lee, Jeong-Hwan Jan 3, 2024 05:40am

• Policy
• Subject drugs with claims over KRW 5 bil for price nego
• by Lee, Tak-Sun Jan 3, 2024 05:40am

• Company
• New antibiotic to be listed for reimb, following Zerbaxa
• by Eo, Yun-Ho Jan 3, 2024 05:40am

• Company
• ‘Drug pricing and reimb' needs most regulatory improvement
• by Chon, Seung-Hyun Jan 3, 2024 05:40am

• Policy
• 430K osteoporotic fractures in 2022, a steep rise over 20 yr
• by Lee, Tak-Sun Jan 2, 2024 05:45am

• Policy
• 5-year relative survival rate of cancer 72.1% in 2021
• by Lee, Jeong-Hwan Jan 2, 2024 05:45am

• Company
• SK Chemicals ends copromotion agreement with Eli Lilly
• by Lee, Tak-Sun Jan 2, 2024 05:45am